Discover 1,846 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Whether you're a healthy volunteer interested in paid studies or someone looking for trials focused on specific conditions, Tennessee offers a wide variety of clinical research options. Leading facilities in Nashville, Memphis, and Knoxville are currently seeking participants, providing opportunities for individuals to access innovative treatments and specialized healthcare.
Filter
1
Filter results
Results: 1,846
Acuvue Oaysis Contact Lens Wearers Being Refit Into P7 Contact Lenses
for
Contact Lens Comfort
Location: Memphis TN
Sponsor: Southern College of Optometry
Sex: All
Age: 18 - 40
Code: NCT06955403
Recruiting
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: St. John's, Boston MA, Norwich CT, New Haven CT, Quebec,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06943872
Phase3, Recruiting
A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.
for
TP53 Y220C Mutation, Advanced Solid Tumors
Location: Orlando FL, Nashville TN, Dallas TX, San Antonio TX,
Sponsor: PMV Pharmaceuticals, Inc
Sex: All
Age: 18+
Code: NCT07372625
Phase1, Recruiting
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
for
Adenovirus Infections
Location: Boston MA, New Hyde Park NY, New York NY, Hackensack NJ,
Sponsor: SymBio Pharmaceuticals
Sex: All
Age: 0+
Code: NCT07387367
Phase3, Recruiting
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
for
Chronic Spontaneous Urticaria (CSU)
Location: Detroit MI, Troy MI, Fairborn OH, Goodlettsville TN,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06868212
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
for
Adjustment Disorder
Location: Boston MA, Worcester MA, New York NY, Philadelphia PA,
Sponsor: Reunion Neuroscience Inc
Sex: All
Age: 18 - 70+
Code: NCT07002034
Phase2, Recruiting
Attentional Mechanisms in SCD
for
Subjective Cognitive Decline
Location: Nashville TN
Sponsor: Vanderbilt University Medical Center
Sex: All
Age: 55+
Code: NCT06002477
Early_phase1, Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Boston MA, Saint Johnsbury VT, Lebanon NH, The Bronx NY,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06532279
Phase2, Recruiting
A Study to Improve Skeletal Muscle in Veterans With HIV
for
HIV, Obesity
Location: Nashville TN
Sponsor: VA Office of Research and Development
Sex: Male
Age: 20 - 70+
Code: NCT06845046
Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
for
Colorectal Cancer
Location: Boston MA, Lake Success NY, Philadelphia PA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07023289
Phase2, Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
for
Ovarian Neoplasms, Ovarian Cancer
Location: Scarborough ME, Providence RI, Chicoutimi, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07318558
Phase3, Recruiting
Nectero EAST System Clinical Study
for
Abdominal Aortic Aneurysm
Location: Scarborough ME, Boston MA, Worcester MA, Lebanon NH,
Sponsor: Nectero Medical, Inc.
Sex: All
Age: 21 - 70+
Code: NCT06001918
Phase2, Phase3, Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: White Plains NY, Schenectady NY, Montreal, Newark DE,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase3, Recruiting
The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study
for
Ischemic Heart Disease (IHD),
Location: Boston MA, Roslyn NY, Richmond VA, Charlottesville VA,
Sponsor: Brigham and Women's Hospital
Sex: All
Age: 35 - 70+
Code: NCT06854458
Recruiting
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
for
Colon Cancer, Rectal Cancer, Colorectal Cancer,
Location: Wynnewood PA, Norfolk VA, Columbia MD, Salem VA,
Sponsor: SCRI Development Innovations, LLC
Sex: All
Age: 18+
Code: NCT07011576
Phase2, Recruiting
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
for
Malignant Glioma
Location: Halifax, Bangor ME, Scarborough ME, Boston MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 21
Code: NCT05099003
Phase1, Phase2, Recruiting
Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Knoxville TN
Sponsor: University of Tennessee Graduate School of Medicine
Sex: All
Age: 40+
Code: NCT07133880
Recruiting
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Halifax, Boston MA, Farmington CT, New Haven CT,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase3, Recruiting
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
for
Non-Hodgkin Lymphoma Refractory/ Relapsed,
Location: New York NY, Buffalo NY, Nashville TN, St Louis MO,